Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective Study

Background. Transcatheter arterial lipiodol chemoembolization (TACE) can be used in cirrhotic patients with hepatocellular carcinoma to avoid tumor progression before transplantation. Objective. To evaluate the efficacy and safety of TACE used as a bridge to liver transplantation. Methods. TACE was...

Full description

Saved in:
Bibliographic Details
Main Authors: Antoine Bouchard-Fortier, Réal Lapointe, Pierre Perreault, Louis Bouchard, Gilles Pomier-Layrargues
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:International Journal of Hepatology
Online Access:http://dx.doi.org/10.4061/2011/974514
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850120630793404416
author Antoine Bouchard-Fortier
Réal Lapointe
Pierre Perreault
Louis Bouchard
Gilles Pomier-Layrargues
author_facet Antoine Bouchard-Fortier
Réal Lapointe
Pierre Perreault
Louis Bouchard
Gilles Pomier-Layrargues
author_sort Antoine Bouchard-Fortier
collection DOAJ
description Background. Transcatheter arterial lipiodol chemoembolization (TACE) can be used in cirrhotic patients with hepatocellular carcinoma to avoid tumor progression before transplantation. Objective. To evaluate the efficacy and safety of TACE used as a bridge to liver transplantation. Methods. TACE was performed in 30 cirrhotic patients with hepatocellular carcinoma. Milan criteria were used to select patients for transplant. Patients had a good or moderately impaired liver function, no arterioportal fistulae, and a good portal perfusion. Results. 48 TACE were performed in 30 patients. Before transplantation, 4 patients were dropped off the list due to tumor extension or liver failure. Complete necrosis of the tumor was observed in 11 patients and partial necrosis in 15 patients. After transplantation, 6 patients died and tumor recurrence was observed in 5 patients with a tumor beyond Milan criteria or no response to TACE. Conclusion. TACE is useful as a bridge to liver transplantation in a selected group of cirrhotic patients with hepatocellular carcinoma. A combined therapeutic approach before surgery might improve the prognosis in these patients.
format Article
id doaj-art-6763e0dbec1f414d9b93bd4d8e0b79be
institution OA Journals
issn 2090-3448
2090-3456
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series International Journal of Hepatology
spelling doaj-art-6763e0dbec1f414d9b93bd4d8e0b79be2025-08-20T02:35:19ZengWileyInternational Journal of Hepatology2090-34482090-34562011-01-01201110.4061/2011/974514974514Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective StudyAntoine Bouchard-Fortier0Réal Lapointe1Pierre Perreault2Louis Bouchard3Gilles Pomier-Layrargues4Department of Surgery, Centre Hospitalier de l'Université de Montréal, 264, East René-Lévesque Blvd, 3rd floor, Montreal, QC, H2X 1P1, CanadaDepartment of Surgery, Centre Hospitalier de l'Université de Montréal, 264, East René-Lévesque Blvd, 3rd floor, Montreal, QC, H2X 1P1, CanadaDepartment of Radiology, Centre Hospitalier de l'Université de Montréal, 264, East René-Lévesque Blvd, 3rd floor, Montreal, QC, H2X 1P1, CanadaDepartment of Radiology, Centre Hospitalier de l'Université de Montréal, 264, East René-Lévesque Blvd, 3rd floor, Montreal, QC, H2X 1P1, CanadaLiver Unit, Centre Hospitalier de l'Université de Montréal, 264, East René-Lévesque Blvd, 3rd floor, Montreal, QC, H2X 1P1, CanadaBackground. Transcatheter arterial lipiodol chemoembolization (TACE) can be used in cirrhotic patients with hepatocellular carcinoma to avoid tumor progression before transplantation. Objective. To evaluate the efficacy and safety of TACE used as a bridge to liver transplantation. Methods. TACE was performed in 30 cirrhotic patients with hepatocellular carcinoma. Milan criteria were used to select patients for transplant. Patients had a good or moderately impaired liver function, no arterioportal fistulae, and a good portal perfusion. Results. 48 TACE were performed in 30 patients. Before transplantation, 4 patients were dropped off the list due to tumor extension or liver failure. Complete necrosis of the tumor was observed in 11 patients and partial necrosis in 15 patients. After transplantation, 6 patients died and tumor recurrence was observed in 5 patients with a tumor beyond Milan criteria or no response to TACE. Conclusion. TACE is useful as a bridge to liver transplantation in a selected group of cirrhotic patients with hepatocellular carcinoma. A combined therapeutic approach before surgery might improve the prognosis in these patients.http://dx.doi.org/10.4061/2011/974514
spellingShingle Antoine Bouchard-Fortier
Réal Lapointe
Pierre Perreault
Louis Bouchard
Gilles Pomier-Layrargues
Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective Study
International Journal of Hepatology
title Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective Study
title_full Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective Study
title_fullStr Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective Study
title_full_unstemmed Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective Study
title_short Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective Study
title_sort transcatheter arterial chemoembolization of hepatocellular carcinoma as a bridge to liver transplantation a retrospective study
url http://dx.doi.org/10.4061/2011/974514
work_keys_str_mv AT antoinebouchardfortier transcatheterarterialchemoembolizationofhepatocellularcarcinomaasabridgetolivertransplantationaretrospectivestudy
AT reallapointe transcatheterarterialchemoembolizationofhepatocellularcarcinomaasabridgetolivertransplantationaretrospectivestudy
AT pierreperreault transcatheterarterialchemoembolizationofhepatocellularcarcinomaasabridgetolivertransplantationaretrospectivestudy
AT louisbouchard transcatheterarterialchemoembolizationofhepatocellularcarcinomaasabridgetolivertransplantationaretrospectivestudy
AT gillespomierlayrargues transcatheterarterialchemoembolizationofhepatocellularcarcinomaasabridgetolivertransplantationaretrospectivestudy